Federated Hermes, Inc.

Equities

FHI

US3142111034

Investment Management & Fund Operators

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
32.91 ^USD	+1.14%		+0.52%	-2.81%

May. 07	Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors	CI
Apr. 29	RBC Capital Cuts Federated Hermes Price Target to $35 From $37, Maintains Sector Perform Rating	MT

Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors

May 06, 2024

On May 7, 2024, Zenas BioPharma, Inc. closed the transaction. The transaction co-led by new investors, SR One Capital Management, LP, New Enterprise Associates, Inc., NVP Associates, LLC, Delos Advisors Limited also included participation from 26 investor sincluding new investors,Enavate Sciences, Longitude Capital Management Co., LLC, Federated Hermes, Inc., ArrowMark Colorado Holdings, LLC, and returning investors, Fairmount Funds Management LLC, Wellington Management Company LLP, Rock Springs Capital Management LP, Pivotal BioVenture Partners LLC, Vivo Capital, LLC, Quan Venture Fund I, L.P., a fund managed by Quan Capital, and Superstring Capital Management LP. As a part of the transaction, Jake Nunn of SR One Capital Management, LP, and Tim Xiao of Delos Advisors Limited joined the company Board of Directors.

Latest news about Federated Hermes, Inc.

Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors	May. 06	CI
RBC Capital Cuts Federated Hermes Price Target to $35 From $37, Maintains Sector Perform Rating	Apr. 29	MT
UBS Adjusts Federated Hermes Price Target to $36 From $39, Maintains Neutral Rating	Apr. 29	MT
Transcript : Federated Hermes, Inc., Q1 2024 Earnings Call, Apr 26, 2024	Apr. 26
Federated Hermes, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 EPS $0.89	Apr. 25	MT
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 Revenue $396.4M	Apr. 25	MT
Federated Hermes, Inc. Declares Special Dividend, Payable on May 15, 2024	Apr. 25	CI
Federated Hermes, Inc. Declares Quarterly Dividend, Payable on May 15, 2024	Apr. 25	CI
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call	Apr. 25
UBS Adjusts Federated Hermes Price Target to $39 From $37, Maintains Neutral Rating	Apr. 12	MT
EMEA Morning Briefing : Stocks Seen Lower; Investors Await Fresh Data for Rate Cut Cues	Mar. 26	DJ
EMEA Morning Briefing : Stocks May Ease After Record Highs	Mar. 22	DJ
Policy uncertainty drives investors into US medium-term bond funds	Mar. 20	RE
AstraZeneca AB entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. for $1.8 billion.	Mar. 18	CI
Regulus Therapeutics Inc. announced that it has received $100.000267 million in funding from a group of investors	Mar. 13	CI
Analysis-Property titans seek clues in Cannes for market turnaround	Mar. 13	RE
Federated Hermes Premier Municipal Income Fund Declares Dividend, Payable on April 1, 2024	Mar. 11	CI
Regulus Therapeutics Inc. announced that it expects to receive $100.000267 million in funding from a group of investors	Mar. 10	CI
Federated Hermes Insider Sold Shares Worth $500,327, According to a Recent SEC Filing	Mar. 07	MT
Xcelerate Pte Ltd announced that it has received $25 million in funding from Federated Hermes, Inc., Altair Capital Advisors Pte Ltd, Exacta Capital Partners, and other investors	Feb. 24	CI
Macquarie plans to cut stake in UK's Cadent - FT	Feb. 18	RE
Hyundai seeks expansion, higher valuation with India IPO	Feb. 14	RE
Federated Hermes Insider Sold Shares Worth $3,200,014, According to a Recent SEC Filing	Feb. 08	MT
Deutsche Bank Adjusts Federated Hermes Price Target to $39 From $38, Maintains Buy Rating	Jan. 29	MT

Chart Federated Hermes, Inc.

Duration

Period

More charts

Company Profile

Federated Hermes, Inc. is an investment management company. The Company operates through a single segment, being the investment management business. It sponsors, markets and provides investment-related services to various investment products, including sponsored investment companies and other funds (Federated Hermes Funds); and Separate Accounts, which include separately managed accounts (SMAs), institutional accounts, sub-advised funds and other managed products in both domestic and international markets. In addition, it markets and provides stewardship and real estate development services to various domestic and international companies. The Company provides investment advisory services to approximately 180 Federated Hermes Funds. It markets these funds to institutional customers and banks, broker/dealers and other financial intermediaries who use them to meet the needs of customers and/or clients, including, among others, retail investors, corporations and retirement plans.

Sector

Investment Management & Fund Operators

Calendar

2024-07-24 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Linda Duessel, Federated Hermes: US-China tension around AI makes investing in China riskier

September 11, 2023 at 04:48 pm EDT

More Strategies

Ratings for Federated Hermes, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

32.91 USD

Average target price

37.25 USD

Spread / Average Target

+13.19%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Investment Management

	1st Jan change	Capi.
FEDERATED HERMES, INC.	-2.81%	2.64B
KKR & CO. INC.	+27.27%	93.57B
BLACKSTONE INC.	-7.42%	92.02B
ARES MANAGEMENT CORPORATION	+21.38%	28.1B
LEGAL & GENERAL PLC	-0.68%	19.12B
THE CARLYLE GROUP INC.	+5.90%	15.51B
AMUNDI	+14.20%	15.86B
FRANKLIN RESOURCES, INC.	-22.56%	12.14B
HDFC ASSET MANAGEMENT COMPANY LIMITED	+21.48%	10.29B
BLUE OWL CAPITAL INC.	+31.21%	10.18B

Investment Management